Daunorubicin (DNR) as a drug for leukemia treatment. Inhibition on topoisomerase II activity with DNR. Decatenated kDNA was incubated with nuclear extracts from Reh treated with DNR (0, 0.02 and 0.05 mg/ml) and compared with linearized kDNA.